Filter
623
Filtered Results: 623
Text search:
molecular
markers
Featured
Recommendations
78
New Publications
123
Language
Document type
No document type
268
Studies & Reports
133
Guidelines
129
Manuals
44
Strategic & Response Plan
24
Training Material
11
Fact sheets
10
Situation Updates
3
Resource Platforms
1
Countries / Regions
India
52
Global
27
Latin America and the Carribbean
16
Kenya
15
Tanzania
14
Western and Central Europe
12
Africa
11
Ethiopia
10
South Africa
9
Nigeria
8
Eastern Europe
8
South–East Asia Region
7
Uganda
6
Sierra Leone
5
Zimbabwe
5
Philippines
5
Ukraine
4
Malawi
4
Asia
4
West and Central Africa
4
Western Pacific Region
4
East and Southern Africa
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
North America
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Iran
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Sri Lanka
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
170
Clinical Guidelines
94
Public Health
40
Pharmacy & Technologies
26
Key Resources
17
Women & Child Health
15
Capacity Building
3
Toolboxes
TB
79
AMR
63
COVID-19
60
HIV
39
Rapid Response
35
NTDs
34
Mental Health
33
Planetary Health
23
Malaria
20
NCDs
17
Ebola & Marburg
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Conflict
4
Disability
3
Cholera
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
Social Ethics
1
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Introduction
Chapter A.13
Polymerase Chain Reaction (PCR) has significantly helped in early diagnosis and commencement of specific interventions for diseases control. It also plays a critical role in understanding the disease epidemiology and unraveling the transmission dynamics of the disease. This manual intends to p...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Towards universal access
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
